PGI3 IMPACT OF DOSE ESCALATION ON TREATMENT COST OF IMMUNOBIOLOGICAL THERAPIES FOR CROHN'S DISEASE FROM THE BRAZILIAN PRIVATE PAYER PERSPECTIVE
Autor: | Fioratti, C., Rachid, M.L., Baida, R., Decimoni, T., Brunelli, M.J. |
---|---|
Zdroj: | In Value in Health Regional Issues October 2019 19 Supplement:S34-S35 |
Databáze: | ScienceDirect |
Externí odkaz: |